Adaptive Biotechnologies Corpor

ADPT

$31.80

Name : Adaptive Biotechnologies Corpor

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $5,147,678,720.00

EPSttm : -0.45

Adaptive Biotechnologies Corpor

$31.80

8.31%

$2.44

ADPT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.63

Margin Of Safety %

Put/Call OI Ratio

0.4

EPS Next Q Diff

-0.12

EPS Last/This Y

-0.15

EPS This/Next Y

0.36

Price

29.39

Target Price

32.57

Analyst Recom

Performance Q

16.28

Upside

-153.6%

Beta

2.14

Ticker: ADPT

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	ADPT	25.58	0.14	0.37	5378
2026-10-13	ADPT	25.28	0.14	0.12	5361
2026-10-14	ADPT	25.62	0.14	0.12	5372
2026-10-15	ADPT	25.57	0.14	0.04	5423
2026-10-16	ADPT	23.94	0.14	1.67	5447
2026-10-19	ADPT	23.95	0.12	0.03	3775
2026-10-20	ADPT	24.42	0.12	0.39	3764
2026-10-21	ADPT	25.33	0.12	0.00	3769
2026-10-22	ADPT	24.39	0.12	0.00	3804
2026-10-23	ADPT	25.5	0.12	0.00	3800
2026-10-26	ADPT	26.3	0.13	0.05	3555
2026-10-27	ADPT	27.67	0.13	0.04	3587
2026-10-28	ADPT	28.36	0.13	0.03	3630
2026-10-29	ADPT	28.17	0.13	0.21	3644
2026-10-30	ADPT	26.63	0.13	0.14	3618
2026-11-02	ADPT	25.05	0.13	0.50	3628
2026-11-03	ADPT	25.79	0.13	0.00	3634
2026-11-04	ADPT	26.71	0.13	1.01	3644
2026-11-05	ADPT	26.8	0.40	0.03	6423
2026-11-06	ADPT	27.97	0.39	0.08	6458
2026-11-09	ADPT	30.26	0.39	0.25	6459
2026-11-10	ADPT	29.36	0.40	0.08	6492
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	ADPT	25.58	-100.0	-	-0.54
2026-10-13	ADPT	25.28	-100.0	-	-0.54
2026-10-14	ADPT	25.61	-100.0	-	-0.54
2026-10-15	ADPT	25.57	-100.0	-	-0.54
2026-10-16	ADPT	24.02	-100.0	-	-0.54
2026-10-19	ADPT	23.95	-100.0	-	-0.54
2026-10-20	ADPT	23.95	-100.0	-	-0.54
2026-10-21	ADPT	24.40	-100.0	-	-0.54
2026-10-22	ADPT	24.40	-100.0	-	-0.54
2026-10-23	ADPT	25.50	-100.0	-	-0.54
2026-10-26	ADPT	26.28	-100.0	-	-0.54
2026-10-27	ADPT	27.66	-100.0	-	-0.54
2026-10-28	ADPT	28.34	-100.0	-	-0.54
2026-10-29	ADPT	28.18	-100.0	-	-0.54
2026-10-30	ADPT	26.64	-100.0	-	-0.54
2026-11-02	ADPT	25.05	-100.0	-	-0.54
2026-11-03	ADPT	25.79	-100.0	-	-0.54
2026-11-04	ADPT	26.75	-100.0	-	-0.54
2026-11-05	ADPT	26.80	-100.0	-	-0.54
2026-11-06	ADPT	27.97	28.8	-	-0.54
2026-11-09	ADPT	30.25	28.8	-	-0.54
2026-11-10	ADPT	29.39	28.8	-	-0.54
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	ADPT	-36.57	3.22	7.65
2026-10-13	ADPT	-36.57	3.22	7.65
2026-10-14	ADPT	-36.39	3.22	7.65
2026-10-15	ADPT	-36.39	3.22	7.65
2026-10-16	ADPT	-36.39	3.22	7.65
2026-10-19	ADPT	-36.20	2.64	7.65
2026-10-20	ADPT	-36.20	2.64	7.65
2026-10-21	ADPT	-36.20	2.64	7.65
2026-10-22	ADPT	-35.91	2.64	7.65
2026-10-23	ADPT	-35.91	2.64	7.65
2026-10-26	ADPT	-35.41	2.31	7.65
2026-10-27	ADPT	-35.72	2.31	7.74
2026-10-28	ADPT	-35.72	2.31	7.74
2026-10-29	ADPT	-35.72	2.31	7.74
2026-10-30	ADPT	-35.87	2.31	7.74
2026-11-02	ADPT	-35.87	2.09	7.74
2026-11-03	ADPT	-35.87	2.09	7.74
2026-11-05	ADPT	-36.18	2.09	7.74
2026-11-06	ADPT	-36.18	2.09	7.74
2026-11-09	ADPT	-36.16	6.81	7.63
2026-11-10	ADPT	-36.16	6.81	7.63
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.02

Avg. EPS Est. Current Quarter

-0.06

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

-36.16

Institutional Transactions

6.81

Beta

2.14

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

16.8

Max Drawdown 5-Year %

-93.2

Target Price

32.57

P/E

Forward P/E

PEG

P/S

15.95

P/B

26.92

P/Free Cash Flow

EPS

-0.45

Average EPS Est. Cur. Y

-0.54

EPS Next Y. (Est.)

-0.18

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-23.66

Relative Volume

0.84

Return on Equity vs Sector %

-66.3

Return on Equity vs Industry %

-51.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ ADPT Healthcare

$29.36

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

8/25

Volume

7/15

Valuation

4/20

TP/AR

4/10

Options

7/10

RSI

60.3

Range 1M

80.3%

Sup Dist

2.1%

🚀

Momentum Growth

Ride accelerating trends

WATCH

Momentum

23/25

Growth

13/30

Estimates

6/20

Inst/Vol

8/15

Options

9/10

EPS Yr

-1.5%

EPS NY

82.3%

52W%

92.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +10.9% upside

Quality

6/30

Valuation

4/30

Growth

10/25

Stability

5/10

LT Trend

4/5

Upside

+10.9%

Quality

ADPT — P/E HistoricalBiotechnology

Adaptive Biotechnologies Corpor

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 624

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

ADPT

Latest News

—

Caricamento notizie per ADPT…

stock quote shares ADPT – Adaptive Biotechnologies Corporation Stock Price stock today

news today ADPT – Adaptive Biotechnologies Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch ADPT – Adaptive Biotechnologies Corporation yahoo finance google finance

stock history ADPT – Adaptive Biotechnologies Corporation invest stock market

stock prices ADPT premarket after hours

ticker ADPT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ADPT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y